Which Country are Merck & Co. and Melior Discovery based out of?
Melior Discovery Melior Discovery, Inc. is a private biopharmaceutical company based in Exton, Pennsylvania, USA. The company specializes in drug repositioning and has established a proprietary phenotypic screening platform that it uses for this purpose. Melior also offers certain contract research organization (CRO) services comprising animal models representing different disease conditions. The Company has issued press releases disclosing partnerships with Pfizer, Merck & Co., Johnson & Johnson, and AstraZeneca, all citing the use of the company’s drug repositioning technology. Melior Discovery has also used its technology to discover its own drug candidates. In March 2009 the Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a type 2 diabetes therapeutic candidate, MLR-1023. In 2013 the company reported a licensing partnership with Bukwang Pharmaceutical Company LTD and the initiation of clinical trials in March 2015. In June 2016 the company reported positive results from their Phase 2a clinical study in diabetic subjects
Prosol Prosol S.p.A. is an Italian biotechnology company headquartered in Madone, Lombardy region, Italy. Founded in 1974, it primarily develops and markets nutritional ingredients for the food industry and livestock area, especially yeast and yeast extracts, nucleotides, ribonucleic acid, probiotics and natural enhancers. Prosol has an in-house developed technology and its plants cover an area of 28000 sq. m, employing about 38 people and working both in domestic and international markets. The company is the original developer and distributor of Biosprint, an active dry yeast used for animal nutrition, and Ribomix, Ribocare, Levimaxi, Brist, Ribonucleic acid trademarks for human nutrition. The company has received the ISO, GMP+, IFS and OHSAS 18001 certifications.